
Group 1 - The establishment of the Private Enterprise Innovation Development Joint Fund marks a significant shift in how private enterprises can engage in basic research, allowing them to participate as "problem setters" in national scientific research [2][3] - The fund has a total investment of 429 million yuan over three years, with an average funding intensity of approximately 2.2 million yuan per project [1][2] - The fund aims to create a collaborative ecosystem that integrates enterprise needs with scientific research capabilities, significantly reducing the cost of research collaboration for companies [3][4] Group 2 - The focus on private enterprises, particularly in the pharmaceutical sector, is due to their rapid development and strong demand for innovation, despite their relatively limited scale and research foundation [4][5] - The initiative encourages private enterprises to increase their investment in basic research, thereby enhancing their core competitiveness and contributing to national economic and social development [2][5] - The fund is expected to facilitate a more effective allocation of innovative resources, aligning them with market demands and fostering a closer integration of scientific research and industrial application [3][4]